Cliff Asness AQR Capital Management
Cliff Asness is a co-founder of AQR Capital Management, a leading quantitative investment firm spanning equities, alternatives, and factor strategies. He is known for academic-informed research on value, momentum, and other systematic premia, as well as candid market commentary. Asness’s work bridges academic finance and large-scale institutional portfolio management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EOG Resources
EOG
|
+$143M |
| 2 |
WNR
Western Refining Inc
WNR
|
+$142M |
| 3 |
DTV
DIRECTV COM STK (DE)
DTV
|
+$137M |
| 4 |
BHI
Baker Hughes
BHI
|
+$135M |
| 5 |
POM
PEPCO HOLDINGS, INC.
POM
|
+$113M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BEAM
BEAM INC COM STK (DE)
BEAM
|
+$215M |
| 2 |
LSI
LSI CORPORATION
LSI
|
+$185M |
| 3 |
Omnicom Group
OMC
|
+$165M |
| 4 |
BRE
BRE PROPERTIES INC CL A
BRE
|
+$95M |
| 5 |
JOSB
JOS A BANK CLOTHIERS INC
JOSB
|
+$83M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.95% |
| 2 | Technology | 13.55% |
| 3 | Financials | 10.47% |
| 4 | Energy | 10.33% |
| 5 | Industrials | 9.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IGR
1276
CBRE Global Real Estate Income Fund
IGR
$709M
| $1.76M | ﹤0.01% |
192,914
+9,628
| +5% | +$83.9K |
|
1277
Nuveen Preferred & Income Opportunities Fund
JPC
$2.82B
| $1.75M | ﹤0.01% |
180,304
-6,890
| -4% | -$65.6K |
|
1278
Glacier Bancorp
GBCI
$6.12B
| $1.75M | ﹤0.01% |
61,574
+200
| +0.3% | +$5.39K |
|
|
AKRX
1279
DELISTED
Akorn Inc
AKRX
| $1.74M | ﹤0.01% |
52,466
-31,400
| -37% | -$823K |
|
1280
Kinder Morgan
KMI
$69.5B
| $1.74M | ﹤0.01% |
47,900
-21,700
| -31% | -$733K |
|
1281
Portland General Electric
POR
$5.87B
| $1.73M | ﹤0.01% |
49,787
| – | – |
|
1282
Celldex Therapeutics
CLDX
$3.24B
| $1.73M | ﹤0.01% |
7,047
+4,137
| +142% | +$934K |
|
1283
Universal Corp
UVV
$1.15B
| $1.72M | ﹤0.01% |
31,130
-1,117
| -3% | -$60.8K |
|
1284
Nexstar Media Group
NXST
$5.78B
| $1.72M | ﹤0.01% |
33,302
-300
| -0.9% | -$12.8K |
|
1285
SBA Communications
SBAC
$19.8B
| $1.72M | ﹤0.01% |
16,800
-7,400
| -31% | -$710K |
|
1286
CVB Financial
CVBF
$3.94B
| $1.72M | ﹤0.01% |
107,158
+17,000
| +19% | +$256K |
|
1287
New Jersey Resources
NJR
$5.46B
| $1.72M | ﹤0.01% |
60,042
+28,600
| +91% | +$744K |
|
|
EE
1288
DELISTED
El Paso Electric Company
EE
| $1.71M | ﹤0.01% |
42,593
-61,463
| -59% | -$2.29M |
|
1289
Eversource Energy
ES
$26.9B
| $1.71M | ﹤0.01% |
36,158
+9,300
| +35% | +$426K |
|
|
ROSE
1290
DELISTED
ROSETTA RESOURCES INC
ROSE
| $1.7M | ﹤0.01% |
31,040
+16,600
| +115% | +$807K |
|
1291
InterDigital
IDCC
$8.87B
| $1.7M | ﹤0.01% |
35,550
-5,000
| -12% | -$193K |
|
|
INVN
1292
DELISTED
Invensense Inc
INVN
| $1.7M | ﹤0.01% |
74,854
+20,900
| +39% | +$427K |
|
|
VAR
1293
DELISTED
Varian Medical Systems, Inc.
VAR
| $1.69M | ﹤0.01% |
+23,150
| New | +$1.66M |
|
|
GWR
1294
DELISTED
Genesee & Wyoming Inc.
GWR
| $1.68M | ﹤0.01% |
15,965
+835
| +6% | +$82.1K |
|
1295
BlackRock Taxable Municipal Bond Trust
BBN
$979M
| $1.68M | ﹤0.01% |
77,172
-38,094
| -33% | -$790K |
|
1296
BlackRock Enhanced Captial and Income Fund
CII
$999M
| $1.67M | ﹤0.01% |
113,118
-148,850
| -57% | -$2.15M |
|
|
FST
1297
DELISTED
FOREST OIL CORPORATION
FST
| $1.67M | ﹤0.01% |
730,592
-1,712,308
| -70% | -$3.65M |
|
|
OSG
1298
Octave Specialty Group
OSG
$205M
| $1.65M | ﹤0.01% |
60,400
-51,800
| -46% | -$1.5M |
|
1299
Vince Holding Corp
VNCE
$80.2M
| $1.65M | ﹤0.01% |
+4,500
| New | +$1.3M |
|
|
ONIT
1300
Onity Group
ONIT
$294M
| $1.65M | ﹤0.01% |
2,962
+1,253
| +73% | +$681K |
|
Similar funds
Cliff Asness's Q2 2014 Portfolio in Review
As of Q2 2014, Cliff Asness held 2,714 positions worth $37.1B, up 12% from $33.1B the previous quarter. Its ten largest holdings account for 8.6% of the portfolio.
Cliff Asness's Q2 2014 filing shows 178 new, 1,030 increased, 953 reduced and 205 closed positions. Its largest new stake was AstraZeneca: 1,186,418 shares worth $88.2M. The largest sale was BEAM INC COM STK (DE), an estimated $215M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
- Cliff Asness's largest Q2 2014 buy was AstraZeneca: 1,186,418 shares worth $88.2M.
- Cliff Asness added most to EOG Resources in Q2 2014, an estimated $143M increase.
- Cliff Asness's biggest Q2 2014 reduction was Omnicom Group, cutting an estimated $165M.
- Cliff Asness fully exited BEAM INC COM STK (DE) in Q2 2014, selling an estimated $215M.
- Cliff Asness's ten largest holdings make up 8.6% of its $37.1B portfolio in Q2 2014.
- Cliff Asness opened 178 new positions and closed 205 in Q2 2014.
- Cliff Asness's portfolio value rose 12% quarter-over-quarter to $37.1B.
Based on AQR Capital Management's 13F filing for Q2 2014, filed 14 Aug 2014.